메뉴 건너뛰기




Volumn 20, Issue 8, 2014, Pages 2205-2214

First-in-human phase i study of lurbinectedin (PM01183) in patients with advanced solid tumors

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATINE KINASE; CREATININE; LURBINECTEDIN; CARBOLINE DERIVATIVE; FUSED HETEROCYCLIC RINGS;

EID: 84898977121     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-1880     Document Type: Article
Times cited : (74)

References (16)
  • 2
    • 0000448995 scopus 로고    scopus 로고
    • Advances in the chemistry and pharmacology of ecteinascidins, a promising new class of anti-cancer agents
    • Manzanares I, Cuevas C, Garcia-Nieto R, Marco E, Gago F. Advances in the chemistry and pharmacology of ecteinascidins, a promising new class of anti-cancer agents. Curr Med Chem Anticancer Agents 2001; 1:257-76.
    • (2001) Curr Med Chem Anticancer Agents , vol.1 , pp. 257-276
    • Manzanares, I.1    Cuevas, C.2    Garcia-Nieto, R.3    Marco, E.4    Gago, F.5
  • 4
    • 84899016922 scopus 로고    scopus 로고
    • In vivo combination studies of PM01183 with alkylating, antimetabolites, DNA-topoisomerase inhibitors and tubulin binding agents [abstract]
    • April 2-6; Orlando FL. Philadelphia, PA: AACR; 2011. Abstract nr 3538
    • Guillen MJ, Catalu~na O, Palomares M, Lopez R, Cuevas C, Aviles P. In vivo combination studies of PM01183 with alkylating, antimetabolites, DNA-topoisomerase inhibitors and tubulin binding agents [abstract]. In: Proceedings of the AACR 102nd Annual Meeting; 2011 April 2-6; Orlando FL. Philadelphia, PA: AACR; 2011. Abstract nr 3538.
    • (2011) Proceedings of the AACR 102nd Annual Meeting
    • Guillen, M.J.1    Cataluna, O.2    Palomares, M.3    Lopez, R.4    Cuevas, C.5    Aviles, P.6
  • 5
    • 80051585674 scopus 로고    scopus 로고
    • Trabectedin and its c subunit modified analogue pm01183 attenuate nucleotide excision repair and show activity toward platinum-resistant cells
    • Soares DG, Machado MS, Rocca CJ, Poindessous V, Ouaret D, Sarasin A, et al. Trabectedin and its C subunit modified analogue PM01183 attenuate nucleotide excision repair and show activity toward platinum-resistant cells. Mol Cancer Ther 2011;10:1481-9.
    • (2011) Mol Cancer Ther , vol.10 , pp. 1481-1489
    • Soares, D.G.1    Machado, M.S.2    Rocca, C.J.3    Poindessous, V.4    Ouaret, D.5    Sarasin, A.6
  • 7
    • 84862179405 scopus 로고    scopus 로고
    • The dna damage response to monofunctional anticancer dna binders
    • Soares DG, Larsen AK, Escargueil AE. The DNA damage response to monofunctional anticancer DNA binders. Drug Discov Today 2012; 9:59-67.
    • (2012) Drug Discov Today , vol.9 , pp. 59-67
    • Soares, D.G.1    Larsen, A.K.2    Escargueil, A.E.3
  • 9
    • 0005932350 scopus 로고    scopus 로고
    • The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit
    • The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit. Note for guidance on the pre-clinical evaluation of anticancer medicinal products. 1998. http://www.iss.it/binary/scf1/cont/CPMP- SWP-997-96.pdf.
    • (1998) Note for Guidance on the Pre-Clinical Evaluation of Anticancer Medicinal Products
  • 11
    • 10244241837 scopus 로고    scopus 로고
    • Phase i clinical trial of cep-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors
    • Undevia SD, Vogelzang NJ, Mauer AM, Janisch L, Mani S, Ratain MJ. Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors. Invest New Drugs 2004;22:449-58.
    • (2004) Invest New Drugs , vol.22 , pp. 449-458
    • Undevia, S.D.1    Vogelzang, N.J.2    Mauer, A.M.3    Janisch, L.4    Mani, S.5    Ratain, M.J.6
  • 13
    • 0034594628 scopus 로고    scopus 로고
    • New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, national cancer institute of the united states, national cancer institute of canada
    • Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92: 205-16.
    • (2000) J Natl Cancer Inst , vol.92 , pp. 205-216
    • Therasse, P.1    Arbuck, S.G.2    Eisenhauer, E.A.3    Wanders, J.4    Kaplan, R.S.5    Rubinstein, L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.